Gene Editing of <i>CCR5</i> in Autologous CD4 T Cells of Persons Infected with HIV

Abstract

CCR5-modified autologous CD4 T-cell infusions are safe within the limits of this study. (Funded by the National Institute of Allergy and Infectious Diseases and others; ClinicalTrials.gov number, NCT00842634.).